- JP-listed companies
- Ownership
(219A) Shareholders
Market cap
¥39.8B
P/E ratio
-18.7x
Heartseed develops regenerative heart muscle therapies using iPS cell-derived cardiac spheres to treat severe heart failure patients through medical institutions worldwide.
大株主
| （単位：千株） | 2024/10 |
|---|---|
| 福田 惠一 | 3,200 14.4% |
| SBI Ventures Two | 2,236.8 10.06% |
| SBI AI&Blockchain投資事業有限責任組合 | 1,539.2 6.93% |
| 古川 俊治 | 1,120 5.04% |
| 秋山 琢己 | 1,120 5.04% |
| 河西 佑太郎 | 800 3.6% |
| Astellas Venture Management LLC． | 708.8 3.19% |
| 日本カストディ銀行 | 616.3 2.77% |
| 新村 健造 | 594.2 2.67% |
| JMDC | 461.6 2.08% |
| 計 | 12,396.9 55.78% |